Bausch Health ehemals VALEANT PHARMA Allergan-Übernahme beflügelt (Seite 89)
eröffnet am 30.04.14 17:10:46 von
neuester Beitrag 10.04.24 21:16:45 von
neuester Beitrag 10.04.24 21:16:45 von
Beiträge: 4.274
ID: 1.193.944
ID: 1.193.944
Aufrufe heute: 14
Gesamt: 389.927
Gesamt: 389.927
Aktive User: 0
ISIN: CA0717341071 · WKN: A2JQ1X · Symbol: BVF
7,5300
EUR
-0,23 %
-0,0170 EUR
Letzter Kurs 16:21:06 Tradegate
Neuigkeiten
02.05.24 · Accesswire |
25.04.24 · wO Chartvergleich |
11.04.24 · Accesswire |
11.04.24 · Accesswire |
Werte aus der Branche Pharmaindustrie
Wertpapier | Kurs | Perf. % |
---|---|---|
1,2000 | +471,16 | |
13,110 | +38,44 | |
0,6300 | +26,28 | |
1,0580 | +22,03 | |
1,2100 | +21,00 |
Wertpapier | Kurs | Perf. % |
---|---|---|
4.155,00 | -20,07 | |
36,70 | -22,87 | |
2,3450 | -25,32 | |
15,600 | -31,64 | |
2,5600 | -70,32 |
Beitrag zu dieser Diskussion schreiben
Xenon Pharmaceuticals (XENE) to Acquire XEN1101 Milestones and Royalties from Bausch Health (BHC)
https://www.streetinsider.com/dr/news.php?id=14595094&gfv=1Die Milestone Zahlungen von Xenon an BHC wurde abgekauft, also durch Einmalzahlung vorab beglichen. Damit ist BHC zur aktuellen Schuldenrückzahlung fähig.
Bausch Health Reduces Debt By Additional $107 Million, Eliminating All Remaining Mandatory Amortization For 2018
https://www.bauschhealth.com/news-room/news-releases/news-de…
https://www.bauschhealth.com/news-room/news-releases/news-de…
Norgine und sein Partner Salix geben die Markteinführung von PLENVU® in den USA bekannt
https://www.finanzen.net/nachricht/aktien/norgine-und-sein-p… Salix Announces U.S. Launch of PLENVU®, the First and Only 1-Liter PEG Bowel Cleansing Preparation for Colonoscopies
http://crweworld.com/article/news-provided-by-pr-newswire/79…
NACDS Recognized LUMIFY as Best-in-Class in Healthcare and Over-the-Counter Category
LUMIFY™ Redness Reliever Eye Drops Honored By The National Association of Chain Drug Stores As Product Showcase Winnerhttps://www.bauschhealth.com/news-room/news-releases/news-de…
https://www.tandfonline.com/action/doSearch?AllField=Methyln…
Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review
https://www.tandfonline.com/doi/full/10.1080/00325481.2016.1…
Overview and Treatment of Opioid-Induced Constipation
https://www.tandfonline.com/doi/abs/10.3810/pgm.2013.07.2651
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
Efficacy of methylnaltrexone for the treatment of opiod-induced constipation: a meta-analysis and systematic review
https://www.tandfonline.com/doi/full/10.1080/00325481.2016.1…
Overview and Treatment of Opioid-Induced Constipation
https://www.tandfonline.com/doi/abs/10.3810/pgm.2013.07.2651
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
https://www.tandfonline.com/doi/full/10.1080/00325481.2018.1…
Salix Pharmaceuticals To Present Clinical Data For The Treatment Of Opioid-Induced Constipation At 2018 PAINWeek Conference
https://markets.businessinsider.com/news/stocks/salix-pharma…
PAINWeek.... kann man so sagen.
https://markets.businessinsider.com/news/stocks/salix-pharma…
PAINWeek.... kann man so sagen.
Why Is Bausch (BHC) Down 10% Since Last Earnings Report?
https://finance.yahoo.com/news/why-bausch-bhc-down-10-142102… 02.05.24 · Accesswire · Bausch Health Companies |
25.04.24 · wO Chartvergleich · BAVARIA Industries Group Akt |
11.04.24 · Accesswire · Bausch Health Companies |
11.04.24 · Accesswire · Bausch Health Companies |
03.04.24 · Accesswire · Bausch Health Companies |
02.04.24 · Accesswire · Bausch Health Companies |
06.03.24 · Accesswire · Bausch Health Companies |
05.03.24 · Accesswire · Bausch Health Companies |
04.03.24 · wO Chartvergleich · Myriad Genetics |
01.03.24 · Accesswire · Bausch Health Companies |